Bold claim: a single Danish sperm donor’s genetic mutation, carried without symptoms, has connected to nearly 200 children worldwide and sparked a global debate about donor limits and screening. Here’s what happened, explained clearly for newcomers to the topic.
A sperm donor who carried a rare genetic mutation that raises cancer risk was used to conceive almost 200 children across the globe. Between 2006 and 2022, the donor’s sperm was distributed to 67 clinics in 14 countries. In Denmark alone, 99 children were conceived using this donor’s sperm.
Public broadcaster DR reported that at least 197 children were born thanks to the anonymous Danish donor, who used the alias Kjeld, before a serious genetic abnormality was detected.
The sequence of events began in April 2020, when Denmark’s European Sperm Bank (ESB), one of the world’s largest banks, learned that a child conceived via donation and diagnosed with cancer carried a genetic mutation. The ESB tested a sample of the donor’s sperm, but the particular TP53 mutation was not found by that screening.
After the initial testing, sales of the donor’s sperm were temporarily paused. Later, sales resumed. Three years later, the bank was informed of at least one more child conceived from the same donation who had developed cancer.
Further testing revealed that the donor did carry the TP53 mutation, though he himself remained healthy. Consequently, the ESB halted the use of his sperm in late October 2023.
A rare and previously undescribed mutation
The Danish Authority on Patient Safety told AFP that 99 children had been born from this donor’s sperm following treatments at clinics.
The ESB explained that, based on a survey of fertility clinics in Denmark using the donor’s sperm, 49 of those children were born to women in Denmark and 50 to women abroad. The mutation is described as rare and not present in the donor’s body overall; only a small portion of his sperm carried the mutation, which is why the donor himself did not show symptoms.
This particular mutation could not be detected by standard pre-screening, and not every child conceived with the donor’s sperm carried the mutation. The ESB notes that more than 70,000 children have been born worldwide with its involvement over the past two decades.
Regulatory landscape and unanswered questions
Many European countries cap how many children can be conceived from a single donor, but there is no universal international rule governing cross-border donations. By the end of 2022, the ESB had set a maximum limit of 75 families per donor.
This case raises important questions about genetic screening, donor limits, cross-border regulation, and how to balance the benefits of assisted reproduction with the need to protect future children from inherited health risks. It also highlights the challenge of detecting rare, embryo- or sperm-specific mutations that may not reflect the donor’s overall health.
What do you think should be the priority for policymakers and clinics in such situations? Should there be stricter, broader genetic screening for donors, tighter limits on the number of children per donor across borders, or a combination of both? Share your thoughts in the comments.
— AFP
